Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence‐enabled automation, education, and training
Autor: | Caitlin Hansen, Lynn Fischer, Joshua G. Hunsberger, Shannon Eaker, Cameron Miller, Preveen Ramamoorthy, Taciana Pereira, Carl G. Simon, Behzad Mahdavi, Claudia Zylberberg, Jed Johnson, Ram Bedi, Kurt Gielen, Priya Baraniak, Michael Hadjisavas, Thomas Tubon |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Engineering education tissue regeneration Regenerative Medicine Commercialization Regenerative medicine Education Unmet needs law.invention Automation 03 medical and health sciences 0302 clinical medicine Artificial Intelligence law stem cells Humans lcsh:QH573-671 health care economics and organizations 3D bioprinting lcsh:R5-920 business.industry lcsh:Cytology Bioprinting Cell Biology General Medicine Outreach Engineering management Treatment Outcome 030104 developmental biology tissue engineering Printing Three-Dimensional Workforce technology Professional association business lcsh:Medicine (General) 030217 neurology & neurosurgery Perspectives Developmental Biology |
Zdroj: | Stem Cells Translational Medicine, Vol 9, Iss 7, Pp 728-733 (2020) Stem Cells Translational Medicine |
ISSN: | 2157-6564 2157-6580 |
Popis: | The Regenerative Medicine Manufacturing Society (RMMS) is the first and only professional society dedicated toward advancing manufacturing solutions for the field of regenerative medicine. RMMS's vision is to provide greater patient access to regenerative medicine therapies through innovative manufacturing solutions. Our mission is to identify unmet needs and gaps in regenerative medicine manufacturing and catalyze the generation of new ideas and solutions by working with private and public stakeholders. We aim to accomplish our mission through outreach and education programs and securing grants for public‐private collaborations in regenerative medicine manufacturing. This perspective will cover four impact areas that the society's leadership team has identified as critical: (a) cell manufacturing and scale‐up/out, respectively, for allogeneic and autologous cell therapies, (b) standards for regenerative medicine, (c) 3D bioprinting, and (d) artificial intelligence‐enabled automation. In addition to covering these areas and ways in which the society intends to advance the field in a collaborative nature, we will also discuss education and training. Education and training is an area that is critical for communicating the current challenges, developing solutions to accelerate the commercialization of the latest technological advances, and growing the workforce in the rapidly expanding sector of regenerative medicine. Depicted are key areas of focus for the Regenerative Medicine Manufacturing Society. Advancing each of these areas will assist in moving the needle forward to improve patient outcomes with regenerative medicine. |
Databáze: | OpenAIRE |
Externí odkaz: |